$11.17-0.07 (-0.62%)
Legacy Education Inc.
Legacy Education Inc. in the Consumer Defensive sector is trading at $11.17. Wall Street consensus targets $14.80 (3 analysts), implying a +32.5% move over the next 12 months. The stock is currently 24% below its 52-week high of $14.70, remaining 0.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Legacy Education Inc. provides education services to students, high school graduates, and working parents in the United States. The company offers degree programs, including Ultrasound Technician, Cardiac Sonography, and Vocational Nursing Associate ...
With a forward P/E ratio of 13.99, Legacy Education Inc. (NYSEAMERICAN:LGCY) is among the 10 Best Growth Stocks to Buy with Low P/E Ratios. On May 15, Mike Grondahl of Northland raised the firm’s price target on Legacy Education Inc. (NYSEAMERICAN:LGCY) to $14.50 from $14 while maintaining an Outperform rating on the shares. The firm revised […]
Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund” Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a sharp macro-driven sector rotation following geopolitical tensions, which triggered inflation fears and rising interest rate […]
Legacy Education (NYSEAMERICAN:LGCY) reported higher revenue and earnings for its fiscal third quarter, with management saying the healthcare education company is benefiting from continued demand for workforce training in nursing, imaging, sonography, surgical technology and other medical support fi
Moby summary of Legacy Education Inc.'s Q3 2026 earnings call
Legacy Education Inc (LGCY) reports a 15% revenue increase and outlines ambitious expansion strategies despite regulatory challenges.